Norway GPFG Healthcare holdings
Norway's Government Pension Fund Global holds 162 healthcare companies worth $ 94.1B — 9.1% of its listed equity value — as of 8 September 2026.
Every position in this sector, largest first. Values are the fund's holding; ownership is the share of the company held.
| Company | Ticker | Country | Fund value (USD) | Fund value (NOK) | Ownership | Voting | Price | P/E | Market cap | Analyst rec |
|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly & Co | LLY | United States | $ 13.1B | kr 129.8B | 1.16% | 1.16% | 1127.90 | 37.89 | $ 1.0T | Buy |
| Johnson & Johnson | JNJ | United States | $ 7.6B | kr 75.1B | 1.24% | 1.24% | 269.21 | 31.27 | $ 648.8B | Buy |
| AstraZeneca PLC | AZN.L | United Kingdom | $ 6.3B | kr 62.6B | 2.18% | 2.18% | 11876.00 | 24.04 | $ 184.2B | Buy |
| AbbVie Inc | ABBV | United States | $ 6.3B | kr 62.6B | 1.42% | 1.42% | 251.24 | 70.97 | $ 444.0B | Buy |
| UnitedHealth Group Inc | UNH | United States | $ 5.0B | kr 49.0B | 1.31% | 1.31% | 400.14 | 25.70 | $ 359.2B | Buy |
| Merck & Co Inc | MRK | United States | $ 4.5B | kr 44.5B | 1.42% | 1.42% | 148.55 | 118.84 | $ 366.5B | Buy |
| Gilead Sciences Inc | GILD | United States | $ 2.6B | kr 25.3B | 1.63% | 1.63% | 146.14 | — | $ 181.2B | Buy |
| Thermo Fisher Scientific Inc | TMO | United States | $ 2.5B | kr 25.2B | 1.37% | 1.37% | 606.29 | 32.60 | $ 224.2B | Buy |
| Bristol-Myers Squibb Co | BMY | United States | $ 2.0B | kr 20.1B | 1.73% | 1.73% | 65.20 | 14.36 | $ 133.2B | Buy |
| Abbott Laboratories | ABT | United States | $ 2.0B | kr 20.0B | 1.29% | 1.29% | 106.06 | 34.32 | $ 183.5B | Buy |
| Intuitive Surgical Inc | ISRG | United States | $ 1.9B | kr 18.7B | 1.34% | 1.34% | 350.48 | 40.15 | $ 125.6B | Buy |
| Danaher Corp | DHR | United States | $ 1.9B | kr 18.3B | 1.37% | 1.37% | 206.11 | 36.74 | $ 144.9B | Strong Buy |
| CVS Health Corp | CVS | United States | $ 1.8B | kr 18.1B | 1.38% | 1.38% | 96.14 | 25.37 | $ 123.0B | Strong Buy |
| Amgen Inc | AMGN | United States | $ 1.8B | kr 17.9B | 0.93% | 0.93% | 393.14 | 24.43 | $ 212.5B | Buy |
| Stryker Corp | SYK | United States | $ 1.5B | kr 15.2B | 1.27% | 1.27% | 280.93 | 29.14 | $ 107.8B | Buy |
| GSK PLC | GSK.L | United Kingdom | $ 1.5B | kr 15.2B | 1.44% | 1.44% | 1796.50 | 15.22 | $ 72.0B | Hold |
| Vertex Pharmaceuticals Inc | VRTX | United States | $ 1.5B | kr 14.8B | 1.19% | 1.19% | 527.35 | 30.75 | $ 133.7B | Buy |
| Pfizer Inc | PFE | United States | $ 1.4B | kr 14.0B | 1.03% | 1.03% | 27.91 | 36.73 | $ 159.1B | Buy |
| Elevance Health Inc | ELV | United States | $ 1.3B | kr 13.3B | 1.60% | 1.6% | 401.06 | 17.73 | $ 87.0B | None |
| McKesson Corp | MCK | United States | $ 1.3B | kr 12.8B | 1.46% | 1.46% | 900.75 | 24.14 | $ 105.0B | Buy |
| Medtronic PLC | MDT | United States | $ 1.3B | kr 12.4B | 1.26% | 1.26% | 92.80 | 22.86 | $ 118.7B | Buy |
| Cigna Group/The | CI | United States | $ 980.7M | kr 9.7B | 1.34% | 1.34% | 276.73 | 11.44 | $ 73.1B | Buy |
| Bayer AG | BAYN.DE | Germany | $ 853.5M | kr 8.4B | 1.57% | 1.57% | 49.41 | — | $ 48.5B | Buy |
| Boston Scientific Corp | BSX | United States | $ 838.5M | kr 8.3B | 1.32% | 1.32% | 45.44 | 18.40 | $ 65.9B | Buy |
| Humana Inc | HUM | United States | $ 791.4M | kr 7.8B | 1.66% | 1.66% | 405.23 | 38.37 | $ 48.7B | Buy |
| HCA Healthcare Inc | HCA | United States | $ 774.8M | kr 7.7B | 0.90% | 0.9% | 398.70 | 13.37 | $ 86.3B | Buy |
| Haleon PLC | HLN.L | United Kingdom | $ 751.3M | kr 7.4B | 1.85% | 1.85% | 337.30 | 18.74 | $ 29.7B | Buy |
| Edwards Lifesciences Corp | EW | United States | $ 740.5M | kr 7.3B | 1.42% | 1.42% | 86.83 | 51.68 | $ 50.0B | Buy |
| Cardinal Health Inc | CAH | United States | $ 717.6M | kr 7.1B | 1.29% | 1.29% | 241.21 | 33.41 | $ 56.1B | Strong Buy |
| Cencora Inc | COR | United States | $ 691.4M | kr 6.8B | 1.26% | 1.26% | 327.22 | 24.29 | $ 62.4B | Buy |
| Alnylam Pharmaceuticals Inc | ALNY | United States | $ 677.6M | kr 6.7B | 1.69% | 1.69% | 261.25 | 45.43 | $ 35.0B | Buy |
| Regeneron Pharmaceuticals Inc | REGN | United States | $ 651.0M | kr 6.4B | 1.00% | 0.86% | 808.01 | 20.01 | $ 83.2B | Buy |
| Becton Dickinson & Co | BDX | United States | $ 600.7M | kr 5.9B | 1.46% | 1.46% | 179.73 | 31.10 | $ 49.0B | Buy |
| Agilent Technologies Inc | A | United States | $ 587.1M | kr 5.8B | 1.57% | 1.57% | 147.61 | 29.11 | $ 41.6B | Buy |
| Biogen Inc | BIIB | United States | $ 579.2M | kr 5.7B | 1.82% | 1.82% | 213.48 | 37.92 | $ 31.5B | Buy |
| Natera Inc | NTRA | United States | $ 512.4M | kr 5.1B | 1.32% | 1.32% | 329.81 | — | $ 47.5B | Strong Buy |
| Revolution Medicines Inc | RVMD | United States | $ 500.2M | kr 4.9B | 1.26% | 1.26% | 209.83 | — | $ 45.0B | Strong Buy |
| Sun Pharmaceutical Industries Ltd | SUNPHARMA.NS | India | $ 483.3M | kr 4.8B | 1.02% | 1.02% | 1885.90 | 37.41 | $ 4.5T | Buy |
| BioMarin Pharmaceutical Inc | BMRN | United States | $ 469.6M | kr 4.6B | 4.25% | 4.25% | 65.27 | 176.41 | $ 12.6B | Buy |
| Merck KGaA | MRK.DE | Germany | $ 448.1M | kr 4.4B | 0.61% | 2.07% | 134.60 | 24.74 | $ 58.5B | Buy |
| Mettler-Toledo International Inc | MTD | United States | $ 423.7M | kr 4.2B | 1.66% | 1.66% | 1334.83 | 30.07 | $ 26.7B | Hold |
| Centene Corp | CNC | United States | $ 412.0M | kr 4.1B | 1.30% | 1.3% | 65.48 | — | $ 32.3B | Buy |
| IQVIA Holdings Inc | IQV | United States | $ 403.9M | kr 4.0B | 1.25% | 1.25% | 264.58 | 32.95 | $ 43.6B | Strong Buy |
| Fresenius SE & Co KGaA | FRE.DE | Germany | $ 389.8M | kr 3.9B | 1.51% | 1.51% | 44.69 | 16.13 | — | Strong Buy |
| Insmed Inc | INSM | United States | $ 381.6M | kr 3.8B | 1.65% | 1.65% | 125.12 | — | $ 27.3B | Strong Buy |
| Dexcom Inc | DXCM | United States | $ 381.1M | kr 3.8B | 1.47% | 1.47% | 84.80 | 33.52 | $ 32.0B | Strong Buy |
| GE HealthCare Technologies Inc | GEHC | United States | $ 376.2M | kr 3.7B | 1.29% | 1.29% | 67.47 | 15.55 | $ 30.5B | Buy |
| Medline Inc | MDLN | United States | $ 370.3M | kr 3.7B | 0.71% | 0.71% | 35.38 | 44.23 | $ 47.6B | Buy |
| Royalty Pharma PLC | RPRX | United States | $ 327.1M | kr 3.2B | 1.01% | 1.01% | 60.05 | 32.28 | $ 34.7B | Strong Buy |
| Roivant Sciences Ltd | ROIV | United States | $ 324.9M | kr 3.2B | 1.28% | 1.28% | 41.92 | — | $ 30.3B | Strong Buy |
| Arrowhead Pharmaceuticals Inc | ARWR | United States | $ 317.3M | kr 3.1B | 2.76% | 2.76% | 85.72 | — | $ 12.1B | Strong Buy |
| West Pharmaceutical Services Inc | WST | United States | $ 303.5M | kr 3.0B | 1.20% | 1.2% | 336.35 | 43.01 | $ 23.7B | Strong Buy |
| United Therapeutics Corp | UTHR | United States | $ 287.0M | kr 2.8B | 1.25% | 1.25% | 501.52 | 17.98 | $ 21.5B | Buy |
| Zoetis Inc | ZTS | United States | $ 282.8M | kr 2.8B | 0.94% | 0.94% | 74.48 | 12.15 | $ 30.8B | Buy |
| Siemens Healthineers AG | SHL.DE | Germany | $ 280.8M | kr 2.8B | 0.64% | 0.64% | 39.00 | 19.80 | $ 43.6B | Buy |
| Tenet Healthcare Corp | THC | United States | $ 269.7M | kr 2.7B | 1.67% | 1.67% | 259.62 | 10.04 | $ 20.9B | Strong Buy |
| Glenmark Pharmaceuticals Ltd | GLENMARK.NS | India | $ 254.6M | kr 2.5B | 3.87% | 3.87% | 2474.50 | 38.82 | $ 698.4B | None |
| STERIS PLC | STE | United States | $ 253.4M | kr 2.5B | 1.23% | 1.23% | 219.97 | 26.89 | $ 21.4B | None |
| Moderna Inc | MRNA | United States | $ 250.6M | kr 2.5B | 0.90% | 0.9% | 144.11 | — | $ 57.5B | Hold |
| Labcorp Holdings Inc | LH | United States | $ 244.3M | kr 2.4B | 1.08% | 1.08% | 325.87 | 26.95 | $ 26.4B | Buy |
| Quest Diagnostics Inc | DGX | United States | $ 239.9M | kr 2.4B | 1.02% | 1.02% | 236.79 | 25.16 | $ 26.1B | Buy |
| Guardant Health Inc | GH | United States | $ 230.5M | kr 2.3B | 1.16% | 1.16% | 165.80 | — | $ 22.2B | Strong Buy |
| Divi's Laboratories Ltd | DIVISLAB.NS | India | $ 225.7M | kr 2.2B | 1.22% | 1.22% | 9575.00 | 87.11 | $ 2.5T | Hold |
| Veeva Systems Inc | VEEV | United States | $ 224.0M | kr 2.2B | 0.78% | 0.78% | 264.22 | 43.24 | $ 42.8B | Buy |
| Apollo Hospitals Enterprise Ltd | APOLLOHOSP.NS | India | $ 214.0M | kr 2.1B | 1.62% | 1.62% | 8837.50 | 60.77 | $ 1.3T | Strong Buy |
| Penumbra Inc | PEN | United States | $ 198.4M | kr 2.0B | 1.60% | 1.6% | 319.86 | 78.78 | $ 12.6B | None |
| Fresenius Medical Care AG | FME.DE | Germany | $ 185.5M | kr 1.8B | 1.54% | 1.54% | 38.79 | 11.68 | $ 10.3B | None |
| Axsome Therapeutics Inc | AXSM | United States | $ 183.4M | kr 1.8B | 1.46% | 1.46% | 207.55 | — | $ 10.9B | Strong Buy |
| Cytokinetics Inc | CYTK | United States | $ 175.3M | kr 1.7B | 1.52% | 1.52% | 75.61 | — | $ 10.5B | Strong Buy |
| Align Technology Inc | ALGN | United States | $ 174.5M | kr 1.7B | 1.44% | 1.44% | 154.52 | 26.83 | $ 11.0B | Buy |
| Smith & Nephew PLC | SN.L | United Kingdom | $ 169.7M | kr 1.7B | 1.39% | 1.39% | 1026.00 | 19.00 | $ 8.6B | Hold |
| QIAGEN NV | QIA.DE | Germany | $ 166.7M | kr 1.6B | 2.07% | 2.07% | 36.47 | 21.58 | $ 7.5B | Buy |
| Cipla Ltd/India | CIPLA.NS | India | $ 160.1M | kr 1.6B | 1.28% | 1.28% | 1384.00 | 33.18 | $ 1.1T | Buy |
| Scholar Rock Holding Corp | SRRK | United States | $ 151.9M | kr 1.5B | 2.30% | 2.3% | 57.01 | — | $ 6.9B | Strong Buy |
| Insulet Corp | PODD | United States | $ 146.7M | kr 1.5B | 1.39% | 1.39% | 141.60 | 26.52 | $ 9.8B | None |
| Charles River Laboratories International Inc | CRL | United States | $ 144.3M | kr 1.4B | 1.32% | 1.32% | 283.68 | — | $ 13.7B | Buy |
| Mankind Pharma Ltd | MANKIND.NS | India | $ 142.6M | kr 1.4B | 1.28% | 1.28% | 2309.00 | 46.77 | $ 953.7B | None |
| Max Healthcare Institute Ltd | MAXHEALTH.NS | India | $ 133.7M | kr 1.3B | 1.15% | 1.15% | 993.00 | 66.73 | $ 966.5B | Buy |
| Dr Reddy's Laboratories Ltd | DRREDDY.NS | India | $ 128.5M | kr 1.3B | 1.07% | 1.07% | 1151.00 | 28.99 | $ 958.8B | Hold |
| Global Health Ltd/India | MEDANTA.NS | India | $ 117.8M | kr 1.2B | 3.16% | 3.16% | 1428.60 | 69.42 | $ 383.9B | Buy |
| Alkermes PLC | ALKS | United States | $ 113.0M | kr 1.1B | 1.29% | 1.29% | 45.87 | 120.71 | $ 7.7B | None |
| Inventurus Knowledge Solutions Ltd | IKS.NS | India | $ 90.3M | kr 893.8M | 2.97% | 2.97% | 1780.00 | 39.82 | $ 298.6B | None |
| Teleflex Inc | TFX | United States | $ 89.4M | kr 884.7M | 1.59% | 1.59% | 136.53 | — | $ 5.8B | Hold |
| JB Chemicals & Pharmaceuticals Ltd | JBCHEPHARM.NS | India | $ 82.5M | kr 816.5M | 2.12% | 2.12% | 2416.10 | 54.22 | $ 387.9B | None |
| Denali Therapeutics Inc | DNLI | United States | $ 72.7M | kr 718.9M | 1.78% | 1.78% | 22.05 | — | $ 3.5B | Strong Buy |
| Enliven Therapeutics Inc | ELVN | United States | $ 70.2M | kr 694.9M | 1.94% | 1.94% | 58.86 | — | $ 4.3B | None |
| BioNTech SE | 22UA.DE | Germany | $ 67.2M | kr 665.3M | 0.29% | 0% | 84.80 | — | $ 21.3B | None |
| Fortis Healthcare Ltd | FORTIS.NS | India | $ 64.2M | kr 635.3M | 0.84% | 0.84% | 908.00 | 65.23 | $ 685.5B | Strong Buy |
| Gland Pharma Ltd | GLAND.NS | India | $ 60.5M | kr 598.6M | 1.39% | 1.39% | 2959.30 | 43.26 | $ 488.2B | None |
| Lupin Ltd | LUPIN.NS | India | $ 59.9M | kr 592.6M | 0.51% | 0.51% | 2104.70 | 17.45 | $ 962.4B | Hold |
| Laurus Labs Ltd | LAURUSLABS.NS | India | $ 56.4M | kr 558.6M | 0.65% | 0.65% | 1946.90 | 96.05 | $ 1.1T | None |
| Torrent Pharmaceuticals Ltd | TORNTPHARM.NS | India | $ 53.1M | kr 525.2M | 0.32% | 0.32% | 4960.00 | 79.47 | $ 1.9T | Buy |
| Concentra Group Holdings Parent Inc | CON | United States | $ 50.7M | kr 501.7M | 1.33% | 1.33% | 34.11 | 22.01 | $ 4.3B | None |
| uniQure NV | QURE | United States | $ 50.7M | kr 501.4M | 1.60% | 1.6% | 44.55 | — | $ 3.1B | Strong Buy |
| Jubilant Pharmova Ltd | JUBILANT.NS | India | $ 50.7M | kr 501.3M | 3.10% | 3.1% | — | — | — | — |
| Alkem Laboratories Ltd | ALKEM.NS | India | $ 50.2M | kr 496.7M | 0.71% | 0.71% | 5181.00 | 28.73 | $ 619.5B | None |
| Generate Biomedicines Inc | GENB | United States | $ 48.5M | kr 480.2M | 2.24% | 2.24% | 15.92 | — | $ 2.0B | Strong Buy |
| GMR Solutions Inc | GMRS | United States | $ 45.6M | kr 451.3M | 1.32% | 5.46% | 14.06 | — | $ 759.5M | Strong Buy |
| Aurobindo Pharma Ltd | AUROPHARMA.NS | India | $ 42.4M | kr 419.4M | 0.44% | 0.44% | 1692.00 | 26.40 | $ 973.5B | Buy |
| Concord Biotech Ltd | CONCORDBIO.NS | India | $ 41.9M | kr 415.0M | 2.96% | 2.96% | 1470.50 | 50.69 | $ 153.8B | None |
| Palvella Therapeutics Inc | PVLA | United States | $ 40.6M | kr 401.6M | 1.85% | 1.85% | 154.28 | — | $ 2.2B | Strong Buy |
| Emcure Pharmaceuticals Ltd | EMCURE.NS | India | $ 38.8M | kr 383.9M | 1.05% | 1.05% | 1925.80 | 36.08 | $ 365.3B | Strong Buy |
| Genus PLC | GNS.L | United Kingdom | $ 37.7M | kr 372.7M | 1.99% | 1.99% | 2290.00 | 32.25 | $ 1.5B | Strong Buy |
| Alivus Life Sciences Ltd | ALIVUS.NS | India | $ 36.0M | kr 356.7M | 2.40% | 2.4% | 1372.00 | 27.98 | $ 168.4B | Strong Buy |
| Sagility Ltd | SAGILITY.NS | India | $ 31.6M | kr 312.5M | 1.62% | 1.62% | 45.70 | 21.56 | $ 213.9B | Strong Buy |
| Sartorius AG | SRT3.DE | Germany | $ 30.6M | kr 303.3M | 0.19% | 0.32% | 238.10 | 84.13 | $ 16.4B | Buy |
| Schott Pharma AG & Co KGaA | 1SXP.DE | Germany | $ 30.5M | kr 301.5M | 1.02% | 1.02% | 23.45 | 26.06 | $ 3.5B | Buy |
| Haw Par Corp Ltd | H02.SI | Singapore | $ 29.5M | kr 292.2M | 1.09% | 1.09% | 13.72 | 13.32 | $ 3.0B | Hold |
| Zydus Lifesciences Ltd | ZYDUSLIFE.NS | India | $ 27.6M | kr 272.9M | 0.23% | 0.23% | 1145.50 | 25.52 | $ 1.1T | Hold |
| Viridian Therapeutics Inc | VRDN | United States | $ 27.5M | kr 271.8M | 1.35% | 1.35% | 23.64 | — | $ 2.7B | Strong Buy |
| Biocon Ltd | BIOCON.NS | India | $ 27.3M | kr 270.5M | 0.38% | 0.38% | 392.30 | 114.04 | — | Buy |
| Cabaletta Bio Inc | CABA | United States | $ 26.9M | kr 266.6M | 5.27% | 5.31% | 3.34 | — | $ 565.6M | Strong Buy |
| Upstream Bio Inc | UPB | United States | $ 26.1M | kr 258.1M | 6.93% | 6.93% | 6.03 | — | $ 330.3M | Buy |
| Ipca Laboratories Ltd | IPCALAB.NS | India | $ 24.5M | kr 242.8M | 0.54% | 0.54% | 1967.20 | 38.04 | $ 499.1B | None |
| Anthem Biosciences Ltd | ANTHEM.NS | India | $ 21.4M | kr 212.2M | 0.47% | 0.47% | 957.80 | 95.02 | $ 538.0B | Strong Buy |
| Perrigo Co PLC | PRGO | United States | $ 20.9M | kr 207.1M | 1.46% | 1.46% | 14.51 | — | $ 2.0B | None |
| Carl Zeiss Meditec AG | AFX.DE | Germany | $ 20.9M | kr 206.6M | 0.77% | 0.77% | 31.18 | 22.76 | $ 2.7B | Underperform |
| Narayana Hrudayalaya Ltd | NH.NS | India | $ 19.7M | kr 194.7M | 0.46% | 0.46% | 1897.40 | 46.81 | $ 385.4B | Strong Buy |
| ORIC Pharmaceuticals Inc | ORIC | United States | $ 19.5M | kr 192.6M | 1.74% | 1.74% | 12.71 | — | $ 1.3B | Strong Buy |
| Bausch Health Cos Inc | BHC.TO | Canada | $ 16.8M | kr 166.5M | 0.91% | 0.91% | 9.00 | — | $ 3.4B | Hold |
| Neuland Laboratories Ltd | NEULANDLAB.NS | India | $ 16.4M | kr 162.3M | 0.65% | 0.65% | 23995.00 | 61.72 | $ 307.9B | None |
| Krishna Institute of Medical Sciences Ltd | KIMS.NS | India | $ 16.3M | kr 161.7M | 0.45% | 0.45% | 764.50 | 149.32 | $ 305.9B | Strong Buy |
| Aster DM Healthcare Ltd | ASTERDM.NS | India | $ 16.0M | kr 158.3M | 0.37% | 0.37% | 790.35 | 128.93 | $ 688.9B | None |
| Lenskart Solutions Ltd | LENSKART.NS | India | $ 15.4M | kr 152.6M | 0.16% | 0.16% | 695.75 | 184.06 | $ 1.2T | Buy |
| SAI Life Sciences Ltd | SAILIFE.NS | India | $ 14.8M | kr 146.9M | 0.54% | 0.54% | 1647.10 | 96.55 | $ 349.8B | None |
| Tandem Diabetes Care Inc | TNDM | United States | $ 14.8M | kr 146.8M | 1.43% | 1.43% | 20.30 | — | $ 1.4B | None |
| Wockhardt Ltd | WOCKPHARMA.NS | India | $ 14.7M | kr 145.6M | 0.44% | 0.44% | 2224.00 | 83.23 | $ 361.4B | None |
| Ajanta Pharma Ltd | AJANTPHARM.NS | India | $ 14.2M | kr 140.6M | 0.31% | 0.31% | 3579.30 | 39.48 | $ 447.3B | None |
| Oxford Nanopore Technologies PLC | ONT.L | United Kingdom | $ 13.2M | kr 130.8M | 0.82% | 0.82% | 158.80 | — | $ 1.6B | Buy |
| Cohance Lifesciences Ltd | COHANCE.NS | India | $ 12.4M | kr 122.5M | 0.67% | 0.67% | 451.60 | 164.82 | $ 172.8B | None |
| Neurogene Inc | NGNE | United States | $ 11.5M | kr 114.3M | 1.85% | 2.32% | 37.44 | — | $ 749.2M | None |
| Draegerwerk AG & Co KGaA | DRW3.DE | Germany | $ 10.9M | kr 108.0M | 0.71% | 1.32% | 110.20 | 12.10 | $ 2.1B | Buy |
| Convatec Group PLC | CTEC.L | United Kingdom | $ 10.9M | kr 107.4M | 0.19% | 0.19% | 221.40 | 44.28 | $ 4.3B | Strong Buy |
| Natco Pharma Ltd | NATCOPHARM.NS | India | $ 10.6M | kr 105.4M | 0.60% | 0.6% | 825.75 | 12.93 | $ 150.6B | None |
| GlaxoSmithKline Pharmaceuticals Ltd | GLAXO.NS | India | $ 10.6M | kr 104.8M | 0.24% | 0.24% | 2928.20 | 46.48 | $ 496.1B | Buy |
| Syngene International Ltd | SYNGENE.NS | India | $ 9.3M | kr 91.7M | 0.49% | 0.49% | 387.55 | 70.59 | $ 156.0B | Buy |
| Raffles Medical Group Ltd | BSL.SI | Singapore | $ 9.2M | kr 91.0M | 0.71% | 0.71% | 0.85 | 21.25 | $ 1.6B | None |
| Rezolute Inc | RZLT | United States | $ 8.8M | kr 87.5M | 1.77% | 1.77% | 4.47 | — | $ 430.4M | Buy |
| Dr Lal PathLabs Ltd | LALPATHLAB.NS | India | $ 8.7M | kr 85.7M | 0.30% | 0.3% | 1912.50 | 59.16 | $ 319.3B | Buy |
| Marksans Pharma Ltd | MARKSANS.NS | India | $ 7.0M | kr 69.8M | 0.54% | 0.54% | 335.90 | 29.49 | $ 152.2B | None |
| Onesource Specialty Pharma Ltd | ONESOURCE.NS | India | $ 6.9M | kr 67.9M | 0.34% | 0.34% | 1579.50 | — | $ 181.1B | None |
| Rainbow Children's Medicare Ltd | RAINBOW.NS | India | $ 6.8M | kr 67.3M | 0.45% | 0.45% | 1449.90 | 51.63 | $ 147.1B | None |
| Strides Pharma Science Ltd | STAR.NS | India | $ 6.8M | kr 67.3M | 0.64% | 0.64% | 1187.40 | 17.83 | $ 109.4B | None |
| Bausch + Lomb Corp | BLCO.TO | Canada | $ 6.7M | kr 66.5M | 0.11% | 0.11% | 24.19 | — | $ 8.6B | Buy |
| PureTech Health PLC | PRTC.L | United Kingdom | $ 6.7M | kr 66.2M | 1.51% | 1.51% | 121.40 | — | $ 297.6M | Strong Buy |
| Poly Medicure Ltd | POLYMED.NS | India | $ 6.4M | kr 63.6M | 0.36% | 0.36% | 1730.10 | 55.58 | $ 175.4B | None |
| Riverstone Holdings Ltd | AP4.SI | Singapore | $ 6.4M | kr 63.4M | 0.65% | 0.65% | 0.80 | 20.00 | $ 1.2B | None |
| Piramal Pharma Ltd | PPLPHARMA.NS | India | $ 6.3M | kr 62.8M | 0.27% | 0.27% | 226.62 | — | $ 300.3B | None |
| Caplin Point Laboratories Ltd | CAPLIPOINT.BO | India | $ 6.0M | kr 59.5M | 0.29% | 0.29% | 2775.45 | 31.82 | $ 211.0B | None |
| Metropolis Healthcare Ltd | METROPOLIS.NS | India | $ 5.2M | kr 51.0M | 0.44% | 0.44% | 582.20 | 59.65 | $ 120.7B | Buy |
| Eris Lifesciences Ltd | ERIS.NS | India | $ 4.9M | kr 48.9M | 0.24% | 0.24% | 1324.70 | 28.26 | $ 183.6B | None |
| UltraGreen.ai Ltd | UGN.SI | Singapore | $ 4.9M | kr 48.5M | 0.36% | 0.36% | — | — | — | — |
| Sun Pharma Advanced Research Co Ltd | SPARC.NS | India | $ 4.7M | kr 46.9M | 0.59% | 0.59% | 203.27 | 4.03 | $ 66.0B | None |
| Procter & Gamble Health Ltd | PGHL.NS | India | $ 4.2M | kr 41.7M | 0.38% | 0.38% | 5603.00 | 26.09 | $ 93.0B | None |
| Alembic Pharmaceuticals Ltd | APLLTD.BO | India | $ 3.9M | kr 38.3M | 0.23% | 0.23% | 809.30 | 22.95 | $ 159.1B | None |
| Jupiter Life Line Hospitals Ltd | JLHL.NS | India | $ 3.9M | kr 38.2M | 0.39% | 0.39% | 283.35 | 49.36 | $ 92.9B | None |
| Hikma Pharmaceuticals PLC | HIK.L | United Kingdom | $ 3.8M | kr 38.1M | 0.09% | 0.09% | 1596.00 | 12.28 | $ 3.3B | Strong Buy |
| Vijaya Diagnostic Centre Ltd | VIJAYA.NS | India | $ 3.6M | kr 35.9M | 0.25% | 0.25% | 1503.00 | 82.95 | $ 154.8B | None |
| Medplus Health Services Ltd | MEDPLUS.NS | India | $ 3.1M | kr 30.5M | 0.30% | 0.3% | 663.45 | 37.80 | $ 79.7B | None |
| STRATEC SE | SBS.DE | Germany | $ 2.9M | kr 28.3M | 1.23% | 1.23% | 24.00 | — | $ 291.7M | Buy |
| Sanofi India Ltd | SANOFI.NS | India | $ 2.1M | kr 21.0M | 0.26% | 0.26% | 3114.90 | 22.17 | $ 71.7B | None |
| Redcare Pharmacy NV | RDC.DE | Germany | $ 283.5K | kr 2.8M | 0.02% | 0.02% | 56.05 | — | $ 1.1B | Buy |